JP Stock MarketDetailed Quotes

3540 CI Medical

Watchlist

898
-19-2.07%

20min DelayMarket Closed Jul 5 15:00 JST

44.90BMarket Cap21.56P/E (Static)

CI Medical Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Quarterly+Annual

YOY

Hide blank lines

(Q1)Mar 31, 2024

(FY)Dec 31, 2023

(Q4)Dec 31, 2023

(Q3)Sep 30, 2023

(Q2)Jun 30, 2023

(Q1)Mar 31, 2023

(FY)Dec 31, 2022

(Q4)Dec 31, 2022

(Q3)Sep 30, 2022

(Q2)Jun 30, 2022

Total revenue

8.61%11.95B

6.38%45.63B

4.88%11.98B

9.01%11.45B

6.18%11.2B

5.59%11B

4.09%42.89B

7.71%11.42B

3.13%10.51B

6.16%10.55B

Cost of revenue

9.43%8.91B

7.74%33.63B

4.42%8.98B

9.04%8.38B

6.56%8.12B

11.50%8.15B

5.47%31.22B

10.60%8.6B

4.07%7.69B

6.32%7.62B

Gross profit

6.28%3.03B

2.76%11.99B

6.23%3B

8.91%3.07B

5.27%3.08B

-8.33%2.85B

0.58%11.67B

-0.21%2.82B

0.64%2.82B

5.72%2.92B

Operating expense

27.01%2.62B

17.22%9B

27.52%2.56B

16.26%2.29B

10.63%2.09B

13.77%2.07B

8.47%7.68B

7.97%2.01B

9.76%1.97B

6.54%1.89B

Operating profit

-48.22%407M

-25.08%2.99B

-46.02%441M

-8.13%780M

-4.56%983M

-39.31%786M

-11.78%3.99B

-15.86%817M

-15.61%849M

4.25%1.03B

Net non-operating interest income (expenses)

-40.00%3M

-20.00%20M

0.00%3M

100.00%6M

-14.29%6M

-58.33%5M

19.05%25M

0.00%3M

-50.00%3M

16.67%7M

Non-operating interest income

28.57%9M

19.35%37M

66.67%10M

166.67%16M

-42.86%4M

-41.67%7M

47.62%31M

100.00%6M

0.00%6M

16.67%7M

Non-operating interest expense

200.00%6M

183.33%17M

133.33%7M

----

--2M

--6M

--3M

----

Net investment income

59.26%-11M

13.33%-13M

266.67%11M

-71.43%2M

104.35%1M

-1,250.00%-27M

-287.50%-15M

150.00%3M

40.00%7M

-2,400.00%-23M

Gain(Loss) on financial instruments designated as cash flow hedges

200.00%164M

-6M

103M

67M

-164M

Gain(Loss) on derecognition of available-for-sale financial assets

54.05%-17M

-62.16%-60M

-64.29%-23M

-37M

64.76%-37M

23.33%-23M

-14M

Income from associates and other participating interests

-9M

51M

Special income (charges)

-51M

Less:Other special charges

---3M

--51M

----

Other non-operating income (expenses)

-20.00%16M

54.72%82M

111.76%36M

-26.09%17M

28.57%9M

233.33%20M

8.16%53M

142.86%17M

130.00%23M

-36.36%7M

Income before tax

-51.72%393M

-17.32%3.18B

-24.42%492M

-9.41%799M

7.26%1.08B

-37.96%814M

-10.13%3.85B

-29.62%651M

-11.98%882M

-2.52%1.01B

Income tax

-51.85%143M

-18.25%1.08B

-36.61%142M

-11.22%277M

5.75%368M

-32.81%297M

-9.43%1.33B

-28.66%224M

-9.04%312M

-1.97%348M

Net income

-51.55%250M

-16.84%2.1B

-17.84%350M

-8.60%521M

8.04%712M

-40.62%516M

-10.50%2.52B

-30.28%426M

-13.51%570M

-2.51%659M

Net income continuous operations

-51.64%250M

-16.83%2.1B

-18.03%350M

-8.42%522M

8.05%711M

-40.57%517M

-10.49%2.53B

-30.11%427M

-13.51%570M

-2.81%658M

Noncontrolling interests

150.00%2M

633.33%16M

333.33%7M

10M

-4M

-3M

Net income attributable to the company

-52.59%247M

-17.41%2.08B

-18.91%343M

-10.00%513M

6.98%705M

-40.05%521M

-10.60%2.52B

-30.77%423M

-13.51%570M

-2.51%659M

Preferred stock dividends

Other under preferred stock dividend

Net income attributable to common stockholders

-52.59%247M

-17.41%2.08B

-18.91%343M

-10.00%513M

6.98%705M

-40.05%521M

-10.60%2.52B

-30.77%423M

-13.51%570M

-2.51%659M

Gross dividend payment

Basic earnings per share

-52.48%4.952

-17.41%41.654

-18.98%6.864

-9.89%10.264

6.96%14.106

-40.05%10.42

-10.61%50.432

-30.75%8.472

-13.58%11.39

-2.40%13.188

Diluted earnings per share

-52.48%4.952

-17.41%41.654

-18.91%6.8601

-9.92%10.2601

6.98%14.1002

-40.05%10.42

-10.61%50.432

-30.77%8.4601

-13.58%11.39

-2.46%13.1801

Dividend per share

0.00%5.044

-10.60%5.044

Currency Unit

JPY

Accounting Standards

NonUS-GAAP

	(Q1)Mar 31, 2024	(FY)Dec 31, 2023	(Q4)Dec 31, 2023	(Q3)Sep 30, 2023	(Q2)Jun 30, 2023	(Q1)Mar 31, 2023	(FY)Dec 31, 2022	(Q4)Dec 31, 2022	(Q3)Sep 30, 2022	(Q2)Jun 30, 2022
Total revenue	8.61%11.95B	6.38%45.63B	4.88%11.98B	9.01%11.45B	6.18%11.2B	5.59%11B	4.09%42.89B	7.71%11.42B	3.13%10.51B	6.16%10.55B
Cost of revenue	9.43%8.91B	7.74%33.63B	4.42%8.98B	9.04%8.38B	6.56%8.12B	11.50%8.15B	5.47%31.22B	10.60%8.6B	4.07%7.69B	6.32%7.62B
Gross profit	6.28%3.03B	2.76%11.99B	6.23%3B	8.91%3.07B	5.27%3.08B	-8.33%2.85B	0.58%11.67B	-0.21%2.82B	0.64%2.82B	5.72%2.92B
Operating expense	27.01%2.62B	17.22%9B	27.52%2.56B	16.26%2.29B	10.63%2.09B	13.77%2.07B	8.47%7.68B	7.97%2.01B	9.76%1.97B	6.54%1.89B
Operating profit	-48.22%407M	-25.08%2.99B	-46.02%441M	-8.13%780M	-4.56%983M	-39.31%786M	-11.78%3.99B	-15.86%817M	-15.61%849M	4.25%1.03B
Net non-operating interest income (expenses)	-40.00%3M	-20.00%20M	0.00%3M	100.00%6M	-14.29%6M	-58.33%5M	19.05%25M	0.00%3M	-50.00%3M	16.67%7M
Non-operating interest income	28.57%9M	19.35%37M	66.67%10M	166.67%16M	-42.86%4M	-41.67%7M	47.62%31M	100.00%6M	0.00%6M	16.67%7M
Non-operating interest expense	200.00%6M	183.33%17M	133.33%7M	----	----	--2M	--6M	--3M	----	----
Net investment income	59.26%-11M	13.33%-13M	266.67%11M	-71.43%2M	104.35%1M	-1,250.00%-27M	-287.50%-15M	150.00%3M	40.00%7M	-2,400.00%-23M
Gain(Loss) on financial instruments designated as cash flow hedges	0	200.00%164M	0	-6M	103M	67M	-164M	-164M	0	0
Gain(Loss) on derecognition of available-for-sale financial assets	54.05%-17M	-62.16%-60M	0	0	-64.29%-23M	-37M	64.76%-37M	23.33%-23M	0	-14M
Income from associates and other participating interests	-9M	51M				0	0
Special income (charges)	3M	-51M	-51M	0	0	0	0	0	0	0
Less:Other special charges	---3M	--51M	----	----	----	----	----	----	----	----
Other non-operating income (expenses)	-20.00%16M	54.72%82M	111.76%36M	-26.09%17M	28.57%9M	233.33%20M	8.16%53M	142.86%17M	130.00%23M	-36.36%7M
Income before tax	-51.72%393M	-17.32%3.18B	-24.42%492M	-9.41%799M	7.26%1.08B	-37.96%814M	-10.13%3.85B	-29.62%651M	-11.98%882M	-2.52%1.01B
Income tax	-51.85%143M	-18.25%1.08B	-36.61%142M	-11.22%277M	5.75%368M	-32.81%297M	-9.43%1.33B	-28.66%224M	-9.04%312M	-1.97%348M
Net income	-51.55%250M	-16.84%2.1B	-17.84%350M	-8.60%521M	8.04%712M	-40.62%516M	-10.50%2.52B	-30.28%426M	-13.51%570M	-2.51%659M
Net income continuous operations	-51.64%250M	-16.83%2.1B	-18.03%350M	-8.42%522M	8.05%711M	-40.57%517M	-10.49%2.53B	-30.11%427M	-13.51%570M	-2.81%658M
Noncontrolling interests	150.00%2M	633.33%16M	333.33%7M	10M	3M	-4M	-3M	-3M	0	0
Net income attributable to the company	-52.59%247M	-17.41%2.08B	-18.91%343M	-10.00%513M	6.98%705M	-40.05%521M	-10.60%2.52B	-30.77%423M	-13.51%570M	-2.51%659M
Preferred stock dividends
Other under preferred stock dividend	0	0	0	0	0	0	0	0	0	0
Net income attributable to common stockholders	-52.59%247M	-17.41%2.08B	-18.91%343M	-10.00%513M	6.98%705M	-40.05%521M	-10.60%2.52B	-30.77%423M	-13.51%570M	-2.51%659M
Gross dividend payment
Basic earnings per share	-52.48%4.952	-17.41%41.654	-18.98%6.864	-9.89%10.264	6.96%14.106	-40.05%10.42	-10.61%50.432	-30.75%8.472	-13.58%11.39	-2.40%13.188
Diluted earnings per share	-52.48%4.952	-17.41%41.654	-18.91%6.8601	-9.92%10.2601	6.98%14.1002	-40.05%10.42	-10.61%50.432	-30.77%8.4601	-13.58%11.39	-2.46%13.1801
Dividend per share	0	0.00%5.044	0.00%5.044	0	0	0	-10.60%5.044	-10.60%5.044	0	0
Currency Unit	JPY	JPY	JPY	JPY	JPY	JPY	JPY	JPY	JPY	JPY
Accounting Standards	NonUS-GAAP	NonUS-GAAP	NonUS-GAAP	NonUS-GAAP	NonUS-GAAP	NonUS-GAAP	NonUS-GAAP	NonUS-GAAP	NonUS-GAAP	NonUS-GAAP

Analysis

Analyst Rating

No Data

Price Target

No Data

Heat List

Overall